Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Coverage Initiated by Analysts at Citigroup

Summary by MarketBeat
Citigroup initiated coverage on Arrowhead Pharmaceuticals in a research note on Tuesday. They set a "buy" rating and a $108.00 price target on the stock.

1 Articles

MarketBeatMarketBeat
Center

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Coverage Initiated by Analysts at Citigroup

Citigroup initiated coverage on Arrowhead Pharmaceuticals in a research note on Tuesday. They set a "buy" rating and a $108.00 price target on the stock.

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Tuesday, September 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Pasadena, California icon

Pasadena, California

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal